Syndecan 1 Antikörper (FITC)
Kurzübersicht für Syndecan 1 Antikörper (FITC) (ABIN2478438)
Target
Alle Syndecan 1 (SDC1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Produktmerkmale
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
- 
                                            Isotyp
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 0.1 mg/mL
 
- 
                                            
- 
    - 
                                            : "CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms."    in: American journal of clinical pathology, Vol. 121, Issue 2, pp. 254-63, (2004)         (PubMed).        
 
 
- 
                                            : "CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms."    in: American journal of clinical pathology, Vol. 121, Issue 2, pp. 254-63, (2004)         (PubMed).        
- 
    - Syndecan 1 (SDC1)
- 
                                            Andere Bezeichnung
- CD138
- 
                                            Hintergrund
- Synonyms: SYNDECAN-1
- 
                                            Gen-ID
- 6382
- 
                                            UniProt
- P18827
- 
                                            Pathways
- Glycosaminoglycan Metabolic Process, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Lipid Metabolism
 Target
- 
                    
 
                                     
                                     
                                    